Moreover, PD-L1 expression is associated with a high frequency of CD8+ TILs, suggesting that PD-L1 expression in CRLM signifies adaptive antitumor immunity, in which TILs are activated in response to tumor antigens. This evidence concerns the gene CD274 and neoplasm.